CHOIR, CREATE, and anemia treatment in patients with CKD

Seminars in Dialysis

Volumn 20, Issue 3, 2007, Pages 277-279

  Berns, Jeffrey S ^a,c   Fishbane, Steven ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34250028943     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2007.00290.x     Document Type: Note

References (16)

1. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D : Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355 : 2085 2098, 2006
2. Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A : Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355 : 2071 2084, 2006
3. K/DOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 47 : S11 S145, 2006
4. Rossert J, Levin A, Roger SD, Horl WH, Fouqueray B, Gassmann-Mayer C, Frei D, McClellan WM : Effect of early correction of anemia on the progression of CKD. Am J Kidney Dis 47 : 738 750, 2006
5. Ritz E, Laville M, Bilous RW, O'Donoghue D, Scherhag A, Burger U, de Alvaro F : Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study. Am J Kidney Dis 49 : 194 207, 2007
6. Macdougall IC, Mark Temple R, Kwan JT : Is early treatment of anaemia with epoetin-[alpha] beneficial to pre-dialysis chronic kidney disease patients? Results of a multicentre, open-label, prospective, randomized, comparative group trial. Nephrol Dial Transplant 22 : 784 793, 2006
7. Parfrey PS, Foley RN, Wittreich BH, Sullivan DJ, Zagari MJ, Frei D : Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. J Am Soc Nephrol 16 : 2180 2189, 2005
8. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA : The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339 : 584 590, 1998
9. Ma JZ, Ebben J, Xia H, Collins AJ : Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 10 : 610 619, 1999
10. Robinson BM, Joffe MM, Berns JS, Pisoni RL, Port FK, Feldman HI : Anemia and mortality in hemodialysis patients: accounting for morbidity and treatment variables updated over time. Kidney Int 68 : 2323 2330, 2005
11. Xia H, Ebben J, Ma JZ, Collins AJ : Hematocrit levels and hospitalization risks in hemodialysis patients. J Am Soc Nephrol 10 : 1309 1316, 1999
12. Roberts TL, Foley RN, Weinhandl ED, Gilbertson DT, Collins AJ : Anaemia and mortality in haemodialysis patients: interaction of propensity score for predicted anaemia and actual haemoglobin levels. Nephrol Dial Transplant 21 : 1652 1662, 2006
13. Levin A : Understanding recent haemoglobin trials in CKD: methods and lesson learned from CREATE and CHOIR. Nephrol Dial Transplant 22 : 309 312, 2007
14. Phrommintikul A, Haas SJ, Elsik M, Krum H : Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 369 : 381 388, 2007
15. Volkova N, Arab L : Evidence-based systematic literature review of hemoglobin/hematocrit and all-cause mortality in dialysis patients. Am J Kidney Dis 47 : 24 36, 2006
16. Strippoli GF, Manno C, Schena FP, Craig JC Haemoglobin and haematocrit targets for the anaemia of chronic renal disease. Cochrane Database Syst Rev CD003967, 2003